Verseon’s Chief Technology Officer Sangtae Kim, a member of the US National Academy of Engineering, says the platform is far more sophisticated than the “AI systems” of other drug developers,…
Verseon’s Chief Technology Officer Sangtae Kim, a member of the US National Academy of Engineering, says the platform is far more sophisticated than the “AI systems” of other drug developers,…